Prognostic Value of Multicolor-Flow Cytometric Measurable Residual Disease Detection in Acute Myeloid Leukemia Prior to Allogeneic Hematopoietic Cell Transplantation: Potential Role of HLA-DR

We implemented a standardized multicolor-flow cytometry approach to monitor MRD in AML patients undergoing alloHCT. MRD positivity predicted inferior OS and RFS, surpassing cytomorphology. Notably, HLA-DR expression on residual leukemic cells was associated with favorable outcomes, highlighting the role of immunogenicity. Comprehensive MRD assessment may enable personalized post-transplant strategies.

Authors

Institutions

Publication Details

Journal
Clinical Lymphoma Myeloma & Leukemia
Published
2025-08-21
DOI
https://doi.org/10.1016/j.clml.2025.08.013
Citations
1
Primary Topic
Acute Myeloid Leukemia Research
Type
article
Field-Weighted Citation Impact
1.77

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prognostic Value of Multicolor-Flow Cytometric Measurable Residual Disease Detection in Acute Myeloid Leukemia Prior to Allogeneic Hematopoietic Cell Transplantation: Potential Role of HLA-DR

Johannes Schetelig, Michael Krämer, Uta Oelschlägel, Christoph Röllig et al.
1 citations
Clinical Lymphoma Myeloma & Leukemia
Acute Myeloid Leukemia Research
1.77
article

Prognostic Value of Multicolor-Flow Cytometric Measurable Residual Disease Detection in Acute Myeloid Leukemia Prior to Allogeneic Hematopoietic Cell Transplantation: Potential Role of HLA-DR

Johannes Schetelig, Michael Krämer, Uta Oelschlägel, Christoph Röllig, Martin Bornhäuser, Ingmar Glauche, Jonas Schadt, Maximilian Alexander Röhnert, Jan Moritz Middeke, Friedrich Stölzel, Desireé Kunadt, Christian Löffler, Friedemann Uschner, Lars Thielecke, Malte von Bonin, Christian Thiede
article en
1 citations

Abstract

We implemented a standardized multicolor-flow cytometry approach to monitor MRD in AML patients undergoing alloHCT. MRD positivity predicted inferior OS and RFS, surpassing cytomorphology. Notably, HLA-DR expression on residual leukemic cells was associated with favorable outcomes, highlighting the role of immunogenicity. Comprehensive MRD assessment may enable personalized post-transplant strategies.

Clinical Lymphoma Myeloma & LeukemiaVol. 25(12)
University Hospital Carl Gustav Carus (DE)
Deutsche Forschungsgemeinschaft, Technische Universität Dresden
Zero hunger
Openalex Percentile: Top 13%
Acute Myeloid Leukemia Research
1.77
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Prognostic Value of Multicolor-Flow Cytometric Measurable Residual Disease Detection in Acute Myeloid Leukemia Prior to Allogeneic Hematopoietic Cell Transplantation: Potential Role of HLA-DR — Johannes Schetelig, Michael Krämer, et al. · Clinical Lymphoma Myeloma & Leukemia (2025) | TGRS Research Map | TGRS